Phenacetin Pharmacokinetics in CYP1A2-Deficient Beagle Dogs
Valerie Whiterock(Bristol-Myers Squibb (United States)), Michael Sinz(Rutgers, The State University of New Jersey), Kimberley A. Lentz(Bristol-Myers Squibb (United States)), Tami Orcutt, Daniel G. Morgan
Cited by 18
Related Papers
CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes
|Drug Metabolism and Disposition|2002|447
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole
|Oncogene|2006|211
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
|Antimicrobial Agents and Chemotherapy|2012|186
Pharmacokinetic Drug Interactions Involving 17??-Ethinylestradiol
|Clinical Pharmacokinetics|2007|174